Oral Agents for Type 2 Diabetes: An Update | Zendy

Bonnie Kimmel | Zendy; Silvio E. Inzucchi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Oral Agents for Type 2 Diabetes: An Update

Author(s) -

Bonnie Kimmel,

Silvio E. Inzucchi

Publication year - 2005

Publication title -

clinical diabetes

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.931

H-Index - 37

eISSN - 1945-4953

pISSN - 0891-8929

DOI - 10.2337/diaclin.23.2.64

Subject(s) - medicine , glycemic , type 2 diabetes , context (archaeology) , intensive care medicine , clinical trial , diabetes mellitus , endocrinology , paleontology , biology

IN BRIEF The paradigms for oral pharmacological therapy in type 2 diabetes areshifting as we attain new insights into the optimal metabolic control in ourpatients. Each drug category has unique advantages and disadvantages, andtheir proper use necessitates a full understanding of their mechanisms ofaction, glycemic and nonglycemic effects, and prescribing indications. Thisarticle reviews published clinical trial data and places them into the contextof contemporary, rational therapeutic strategies for this increasingly commoncondition.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research